M&A Deal Summary

bioMerieux Acquires BioFire Diagnostics

On January 16, 2014, bioMerieux acquired medical products company BioFire Diagnostics for 450M USD

Acquisition Highlights
  • This is bioMerieux’s 5th transaction in the Medical Products sector.
  • This is bioMerieux’s largest (disclosed) transaction.
  • This is bioMerieux’s 6th transaction in the United States.
  • This is bioMerieux’s 1st transaction in Utah.

M&A Deal Summary
Date 2014-01-16
Target BioFire Diagnostics
Sector Medical Products
Buyer(s) bioMerieux
Deal Type Add-on Acquisition
Deal Value 450M USD

Target

BioFire Diagnostics

Salt Lake City, Utah, United States
BioFire Diagnostics, Inc. is a specialized in molecular biology. BioFire Diagnostics developing products with a firm commitment to eliminate disease through smart thinking and product innovation.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

bioMerieux

Marcy l'Etoile, France
Category Company
Founded 1963
Sector Life Science
Employees13,409
Revenue 3.7B EUR (2023)
DESCRIPTION

bioMerieux is a provider in the field of in vitro diagnostics. bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy l'Etoile, France.

DEAL STATS #
Overall 15 of 21
Sector (Medical Products) 5 of 9
Type (Add-on Acquisition) 12 of 17
State (Utah) 1 of 1
Country (United States) 6 of 8
Year (2014) 1 of 2
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-19 Argene SA

Verniolle, France

Argene SA is a specialized in molecular diagnostics company.

Buy €38M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-22 Advencis Sarl

Mutzig, France

Advencis Sarl are an innovative company in instrumentation for the Life Sciences & Healthcare sectors. Company focus is on developing innovative and easy-to-use products for customers that deliver highly valued benefits to final users.

Buy -
Mergr

Product

Company

Legal